[HTML][HTML] Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives

S Roy, S Dhaneshwar - World Journal of Gastroenterology, 2023 - ncbi.nlm.nih.gov
Experimental evidence supports the fact that changes in the bowel microflora due to
environmental or dietary factors have been investigated as implicating factors in the …

The oral-gut axis: periodontal diseases and gastrointestinal disorders

GA Lam, H Albarrak, CJ McColl… - Inflammatory bowel …, 2023 - academic.oup.com
One of the prospective sequelae of periodontal disease (PD), chronic inflammation of the
oral mucosa, is the development of inflammatory gastrointestinal (GI) disorders due to the …

[HTML][HTML] Complementary and alternative medicine (CAM)

F Taheri, M Farrokhi, Y Rajabloo, N Razavi, E Shirdel… - Kindle, 2024 - preferpub.org
Abstract Complementary and Alternative Medicine (CAM) encompasses a diverse array of
practices and therapies not typically part of conventional medical care. CAM includes natural …

[HTML][HTML] Cannabinoids and opioids in the treatment of inflammatory bowel diseases

M Kienzl, M Storr, R Schicho - Clinical and translational …, 2020 - journals.lww.com
In traditional medicine, Cannabis sativa has been prescribed for a variety of diseases.
Today, the plant is largely known for its recreational purpose, but it may find a way back to …

Probiotics in the treatment of inflammatory bowel disease

S Guandalini, N Sansotta - … and Child Gastrointestinal Health: Advances in …, 2019 - Springer
While considerable progress has been made in the treatment of inflammatory bowel
diseases (IBD), alternative options are constantly sought by adult patients as well as …

[HTML][HTML] The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy

S Yuan, KS Wang, H Meng, XT Hou, JC Xue… - Biomedicine & …, 2023 - Elsevier
Gut microbes constitute the main microbiota in the human body, which can regulate
biological processes such as immunity, cell proliferation, and differentiation, hence playing a …

Lactobacillus paracasei L9 improves colitis by expanding butyrate-producing bacteria that inhibit the IL-6/STAT3 signaling pathway

M Deng, X Wu, X Duan, J Xu, X Yang, X Sheng… - Food & function, 2021 - pubs.rsc.org
Inflammatory bowel disease (IBD) is a chronic intestinal inflammation that is currently
incurable. Increasing evidence indicates that supplementation with probiotics could improve …

Oral targeted delivery by nanoparticles enhances efficacy of an Hsp90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated …

M Yang, F Zhang, C Yang, L Wang… - Journal of Crohn's …, 2020 - academic.oup.com
Abstract Background and Aims Heat shock protein 90 [Hsp90]-targeted therapy has been
proposed as a promising strategy for the treatment of ulcerative colitis [UC] and colitis …

Limosilactobacillus fermentum CECT5716: Mechanisms and Therapeutic Insights

MJ Rodríguez-Sojo, AJ Ruiz-Malagón… - Nutrients, 2021 - mdpi.com
Probiotics microorganisms exert their health-associated activities through some of the
following general actions: competitive exclusion, enhancement of intestinal barrier function …

Microbiome-and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model

S Sharma, VS Gilberto, CL Levens… - ACS Pharmacology & …, 2024 - ACS Publications
Autoimmune and autoinflammatory diseases account for more than 80 chronic conditions
affecting more than 24 million people in the US. Among these autoinflammatory diseases …